Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Balance Sheet
Balance Sheet Decomposition
Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals PLC
Balance Sheet
Jazz Pharmaceuticals PLC
| Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||
| Cash & Cash Equivalents |
21
|
79
|
103
|
25
|
16
|
45
|
82
|
387
|
637
|
684
|
989
|
366
|
386
|
216
|
333
|
517
|
511
|
851
|
1 506
|
2 413
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
216
|
333
|
517
|
511
|
334
|
438
|
949
|
|
| Cash Equivalents |
21
|
79
|
103
|
25
|
16
|
45
|
82
|
387
|
637
|
684
|
989
|
366
|
386
|
0
|
0
|
0
|
0
|
517
|
1 069
|
1 464
|
|
| Short-Term Investments |
0
|
0
|
0
|
1
|
0
|
0
|
76
|
0
|
0
|
0
|
0
|
60
|
215
|
609
|
744
|
1 616
|
81
|
30
|
120
|
580
|
|
| Total Receivables |
4
|
5
|
5
|
7
|
12
|
22
|
34
|
75
|
125
|
186
|
210
|
234
|
224
|
264
|
356
|
396
|
563
|
743
|
855
|
717
|
|
| Accounts Receivables |
4
|
5
|
5
|
7
|
12
|
22
|
34
|
75
|
125
|
186
|
210
|
234
|
224
|
264
|
356
|
396
|
563
|
651
|
706
|
717
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
92
|
149
|
0
|
|
| Inventory |
3
|
3
|
2
|
4
|
3
|
5
|
4
|
27
|
29
|
30
|
19
|
34
|
43
|
53
|
79
|
95
|
1 073
|
714
|
597
|
480
|
|
| Other Current Assets |
4
|
4
|
5
|
7
|
6
|
3
|
3
|
62
|
74
|
116
|
40
|
54
|
100
|
93
|
118
|
214
|
383
|
268
|
357
|
439
|
|
| Total Current Assets |
31
|
92
|
116
|
44
|
37
|
74
|
199
|
552
|
865
|
1 016
|
1 258
|
748
|
968
|
1 234
|
1 630
|
2 840
|
2 611
|
2 606
|
3 435
|
4 629
|
|
| PP&E Net |
2
|
2
|
4
|
3
|
1
|
1
|
2
|
7
|
14
|
58
|
86
|
107
|
170
|
200
|
271
|
257
|
343
|
301
|
235
|
227
|
|
| PP&E Gross |
2
|
2
|
4
|
3
|
1
|
1
|
2
|
7
|
14
|
58
|
86
|
107
|
170
|
200
|
271
|
257
|
343
|
301
|
235
|
227
|
|
| Accumulated Depreciation |
1
|
1
|
3
|
4
|
5
|
6
|
7
|
8
|
11
|
15
|
24
|
32
|
41
|
50
|
55
|
68
|
85
|
108
|
133
|
162
|
|
| Intangible Assets |
79
|
69
|
36
|
33
|
30
|
22
|
15
|
870
|
812
|
1 437
|
1 186
|
3 012
|
2 979
|
2 731
|
2 441
|
2 195
|
7 152
|
5 794
|
5 418
|
4 756
|
|
| Goodwill |
39
|
38
|
38
|
38
|
38
|
38
|
38
|
443
|
450
|
703
|
657
|
894
|
948
|
928
|
920
|
958
|
1 828
|
1 693
|
1 753
|
1 716
|
|
| Other Long-Term Assets |
14
|
14
|
13
|
0
|
1
|
0
|
0
|
95
|
97
|
125
|
147
|
39
|
59
|
110
|
277
|
286
|
364
|
441
|
552
|
684
|
|
| Other Assets |
39
|
38
|
38
|
38
|
38
|
38
|
38
|
443
|
450
|
703
|
657
|
894
|
948
|
928
|
920
|
958
|
1 828
|
1 693
|
1 753
|
1 716
|
|
| Total Assets |
165
N/A
|
215
+30%
|
208
-3%
|
117
-44%
|
107
-9%
|
136
+27%
|
254
+87%
|
1 966
+674%
|
2 238
+14%
|
3 339
+49%
|
3 333
0%
|
4 800
+44%
|
5 124
+7%
|
5 203
+2%
|
5 539
+6%
|
6 536
+18%
|
12 299
+88%
|
10 835
-12%
|
11 393
+5%
|
12 012
+5%
|
|
| Liabilities | |||||||||||||||||||||
| Accounts Payable |
5
|
5
|
3
|
6
|
2
|
3
|
5
|
16
|
21
|
25
|
22
|
22
|
24
|
41
|
48
|
27
|
100
|
91
|
103
|
78
|
|
| Accrued Liabilities |
11
|
13
|
29
|
16
|
12
|
13
|
20
|
105
|
120
|
164
|
164
|
193
|
199
|
263
|
267
|
349
|
647
|
803
|
793
|
900
|
|
| Short-Term Debt |
0
|
2
|
3
|
4
|
9
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
119
|
24
|
16
|
0
|
30
|
6
|
9
|
38
|
36
|
41
|
33
|
33
|
246
|
31
|
31
|
605
|
31
|
|
| Other Current Liabilities |
7
|
10
|
1
|
29
|
12
|
20
|
28
|
41
|
58
|
18
|
3
|
6
|
30
|
8
|
17
|
31
|
30
|
8
|
36
|
29
|
|
| Total Current Liabilities |
23
|
31
|
37
|
173
|
59
|
60
|
53
|
192
|
204
|
217
|
227
|
257
|
294
|
345
|
364
|
654
|
809
|
933
|
1 537
|
1 039
|
|
| Long-Term Debt |
89
|
74
|
75
|
0
|
91
|
25
|
0
|
427
|
544
|
1 333
|
1 151
|
1 994
|
1 540
|
1 563
|
1 574
|
1 849
|
6 025
|
5 699
|
5 113
|
6 082
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
178
|
168
|
375
|
283
|
557
|
383
|
309
|
224
|
130
|
1 301
|
944
|
848
|
677
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
14
|
27
|
24
|
30
|
21
|
8
|
48
|
26
|
43
|
73
|
115
|
193
|
228
|
265
|
243
|
198
|
173
|
159
|
121
|
|
| Total Liabilities |
113
N/A
|
119
+5%
|
139
+17%
|
198
+42%
|
180
-9%
|
105
-42%
|
61
-42%
|
845
+1 285%
|
943
+12%
|
1 968
+109%
|
1 734
-12%
|
2 923
+69%
|
2 411
-18%
|
2 446
+1%
|
2 428
-1%
|
2 876
+18%
|
8 333
+190%
|
7 750
-7%
|
7 656
-1%
|
7 919
+3%
|
|
| Equity | |||||||||||||||||||||
| Common Stock |
164
|
264
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
118
|
178
|
316
|
501
|
508
|
475
|
350
|
61
|
19
|
35
|
303
|
529
|
918
|
842
|
1 068
|
1 160
|
831
|
734
|
879
|
1 128
|
|
| Additional Paid In Capital |
0
|
1
|
371
|
408
|
435
|
505
|
543
|
1 151
|
1 220
|
1 458
|
1 563
|
1 665
|
1 935
|
2 114
|
2 266
|
2 634
|
3 535
|
3 477
|
3 700
|
3 914
|
|
| Other Equity |
6
|
8
|
13
|
12
|
0
|
0
|
0
|
31
|
56
|
122
|
267
|
317
|
141
|
198
|
223
|
134
|
400
|
1 126
|
842
|
948
|
|
| Total Equity |
52
N/A
|
96
+85%
|
68
-29%
|
80
N/A
|
73
+9%
|
31
N/A
|
193
+523%
|
1 121
+481%
|
1 296
+16%
|
1 371
+6%
|
1 599
+17%
|
1 877
+17%
|
2 713
+45%
|
2 757
+2%
|
3 111
+13%
|
3 660
+18%
|
3 965
+8%
|
3 086
-22%
|
3 737
+21%
|
4 094
+10%
|
|
| Total Liabilities & Equity |
165
N/A
|
215
+30%
|
208
-3%
|
117
-44%
|
107
-9%
|
136
+27%
|
254
+87%
|
1 966
+674%
|
2 238
+14%
|
3 339
+49%
|
3 333
0%
|
4 800
+44%
|
5 124
+7%
|
5 203
+2%
|
5 539
+6%
|
6 536
+18%
|
12 299
+88%
|
10 835
-12%
|
11 393
+5%
|
12 012
+5%
|
|
| Shares Outstanding | |||||||||||||||||||||
| Common Shares Outstanding |
25
|
25
|
25
|
29
|
31
|
40
|
42
|
58
|
58
|
61
|
61
|
60
|
60
|
58
|
56
|
56
|
62
|
63
|
62
|
61
|
|
| Preferred Shares Outstanding |
11
|
18
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|